Skip to main content

Advertisement

Log in

Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women’s Health Initiative

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Risk for falls and fractures increases after breast cancer or other cancer diagnosis in postmenopausal women. Factors other than falls may be the major causes for the increased fracture risk.

Introduction

Cancer treatment and prognosis may have detrimental effects on bone health. However, there is a lack of prospective investigations on fracture risk among incident cancer cases.

Methods

In this study, postmenopausal women (N = 146,959) from the Women’s Health Initiative prospective cohort, who had no cancer history at baseline, were followed for up to 9 years and classified into no cancer, incident breast cancer (BC) and incident other cancer (OC) groups. The main outcomes measured were incident fractures and falls before and after cancer diagnosis. Hazards ratios (HR) and 95% confidence intervals (CI) were computed from Cox proportional hazards model.

Results

While hip fracture risk before a cancer diagnosis was similar between the no cancer and cancer groups, hip fracture risk was significantly higher after BC diagnosis (HR = 1.55, CI = 1.13–2.11) and the elevated risk was even more notable after OC diagnosis (HR = 2.09, CI = 1.65–2.65). Risk of falls also increased after BC (HR = 1.15, CI = 1.06–1.25) or OC diagnosis (HR = 1.27, CI = 1.18–1.36), but could not fully explain the elevated hip fracture risk. Incident clinical vertebral and total fractures were also significantly increased after OC diagnosis (p < 0.05).

Conclusions

Postmenopausal women have significantly elevated risks for falls and fractures after a cancer diagnosis. The causes for this increased risk remained to be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767

    Article  Google Scholar 

  2. Cauley JA, Lucas FL, Kuller LH et al (1996) Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. Jama 276:1404–1408

    Article  Google Scholar 

  3. Newcomb PA, Trentham-Dietz A, Egan KM et al (2001) Fracture history and risk of breast and endometrial cancer. Am J Epidemiol 153:1071–1078

    Article  Google Scholar 

  4. Chen Z, Maricic M, Pettinger M et al (2005) Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer 104:1520–1530

    Article  Google Scholar 

  5. Friedlaender GE, Tross RB, Doganis AC et al (1984) Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am 66:602–607

    Google Scholar 

  6. May KP, West SG, McDermott MT et al (1994) The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 37:201–206

    Article  Google Scholar 

  7. Twiss JJ, Waltman N, Ott CD et al (2001) Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract 13:276–284

    Google Scholar 

  8. Chen Z, Maricic M, Bassford TL et al (2005) Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study. Arch Intern Med 165:552–558

    Article  Google Scholar 

  9. Michaud LB, Goodin S (2006) Cancer-treatment-induced bone loss, part 1. Am J Health Syst Pharm 63:419–430

    Article  Google Scholar 

  10. Rivara FP, Grossman DC, Cummings P (1997) Injury prevention. Second of two parts. N Engl J Med 337:613–618

    Article  Google Scholar 

  11. WHI (1998) Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group. Control Clin Trials 19:61–109

    Article  Google Scholar 

  12. Langer RD, White E, Lewis CE et al (2003) The Women’s Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107–121

    Article  Google Scholar 

  13. Chen Z, Kooperberg C, Pettinger MB et al (2004) Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women’s Health Initiative observational study and clinical trials. Menopause 11:264–274

    Article  Google Scholar 

  14. Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. New York, Wiley

    Google Scholar 

  15. Cauley JA, Wu L, Wampler NS et al (2007) Clinical risk factors for fractures in multiethnic women: The Women’s Health Initiative. J Bone Miner Res 22:1816–1826

    Article  Google Scholar 

  16. Prentice RL (1989) Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8:431–440

    Article  Google Scholar 

  17. Delmas PD, Fontana A (1998) Bone loss induced by cancer treatment and its management. Eur J Cancer 34:260–262

    Article  Google Scholar 

  18. Adami HO, Zack M, Kressner U et al (1990) Hip fractures in women with breast cancer. Am J Epidemiol 132:877–883

    Google Scholar 

  19. Kanis JA, McCloskey EV, Powles T et al (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179–1181

    Article  Google Scholar 

  20. Lamont EB, Lauderdale DS (2003) Low risk of hip fracture among elderly breast cancer survivors. Ann Epidemiol 13:698–703

    Article  Google Scholar 

  21. Chang J, Powles TJ, Ashley SE et al (1996) The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. Ann Oncol 7:671–675

    Google Scholar 

  22. Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388

    Article  Google Scholar 

  23. Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319:1701–1707

    Google Scholar 

  24. Nevitt MC, Cummings SR, Hudes ES (1991) Risk factors for injurious falls: a prospective study. J Gerontol 46:M164–170

    Google Scholar 

  25. Greenspan SL, Bhattacharya RK, Sereika SM et al (2007) Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 92:131–136

    Article  Google Scholar 

Download references

Acknowledgment

The WHI program is funded by the National Heart, Lung and Blood Institute, U.S. Department of Health and Human Services. No additional funding was received for this project. The authors had full access to all of the data in the study, take responsibility for the integrity of the data, and the accuracy of the data analysis.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Z. Chen.

Appendix 

Appendix 

Program Office: (National Heart, Lung, and Blood Institute, Bethesda, Maryland) Elizabeth Nabel, Jacques Rossouw, Shari Ludlam, Linda Pottern, Joan McGowan, Leslie Ford, and Nancy Geller.

Clinical Coordinating Center: (Fred Hutchinson Cancer Research Center, Seattle, WA) Ross Prentice, Garnet Anderson, Andrea LaCroix, Charles L. Kooperberg, Ruth E. Patterson, Anne McTiernan; (Wake Forest University School of Medicine, Winston-Salem, NC) Sally Shumaker; (Medical Research Labs, Highland Heights, KY) Evan Stein; (University of California at San Francisco,CA) Steven Cummings.

Clinical Centers: (Albert Einstein College of Medicine, Bronx, NY) Sylvia Wassertheil-Smoller; (Baylor College of Medicine, Houston, TX) Jennifer Hays; (Brigham and Women's Hospital, Harvard Medical School, Boston, MA) JoAnn Manson; (Brown University, Providence, RI) Annlouise R. Assaf; (Emory University, Atlanta, GA) Lawrence Phillips; (Fred Hutchinson Cancer Research Center, Seattle, WA) Shirley Beresford; (George Washington University Medical Center, Washington, DC) Judith Hsia; (Los Angeles Biomedical Research Institute at Harbor- UCLA Medical Center, Torrance, CA) Rowan Chlebowski; (Kaiser Permanente Center for Health Research, Portland, OR) Evelyn Whitlock (Kaiser Permanente Division of Research, Oakland, CA) Bette Caan; (Medical College of Wisconsin, Milwaukee, WI) Jane Morley Kotchen; (MedStar Research Institute/Howard University, Washington, DC) Barbara V. Howard; (Northwestern University, Chicago/Evanston, IL) Linda Van Horn; (Rush Medical Center, Chicago, IL) Henry Black; (Stanford Prevention Research Center, Stanford, CA) Marcia L. Stefanick; (State University of New York at Stony Brook, Stony Brook, NY) Dorothy Lane; (The Ohio State University, Columbus, OH) Rebecca Jackson; (University of Alabama at Birmingham, Birmingham, AL) Cora E. Lewis; (University of Arizona, Tucson/Phoenix, AZ) Tamsen Bassford; (University at Buffalo, Buffalo, NY) Jean Wactawski-Wende; (University of California at Davis, Sacramento, CA) John Robbins; (University of California at Irvine, CA) F. Allan Hubbell; (University of California at Los Angeles, Los Angeles, CA) Howard Judd; (University of California at San Diego, LaJolla/Chula Vista, CA) Robert D. Langer; (University of Cincinnati, Cincinnati, OH) Margery Gass; (University of Florida, Gainesville/Jacksonville, FL) Marian Limacher; (University of Hawaii, Honolulu, HI) David Curb; (University of Iowa, Iowa City/Davenport, IA) Robert Wallace; (University of Massachusetts/Fallon Clinic, Worcester, MA) Judith Ockene; (University of Medicine and Dentistry of New Jersey, Newark, NJ) Norman Lasser; (University of Miami, Miami, FL) Mary Jo O’Sullivan; (University of Minnesota, Minneapolis, MN) Karen Margolis; (University of Nevada, Reno, NV) Robert Brunner; (University of North Carolina, Chapel Hill, NC) Gerardo Heiss; (University of Pittsburg, Pittsburg, PA) Lewis Kuller; (University of Tennessee, Memphis, TN) Karen C. Johnson; (University of Texas Health Science Center, San Antonio, TX) Robert Brzyski; (University of Wisconsin, Madison, WI) Gloria E. Sarto; (Wake Forest University School of Medicine, Winston-Salem, NC) Denise Bonds; (Wayne State University School of Medicine/Hutzel Hospital, Detroit, MI) Susan Hendrix.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Z., Maricic, M., Aragaki, A.K. et al. Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women’s Health Initiative. Osteoporos Int 20, 527–536 (2009). https://doi.org/10.1007/s00198-008-0721-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-008-0721-0

Keywords

Navigation